Overview

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Status:
Completed
Trial end date:
2021-01-29
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety of long-term treatment with Kuvan.
Details
Lead Sponsor:
BioMarin Pharmaceutical